Northwest Biotherapeutics Inc (NWBO)
0.48
-0.03
(-5.88%)
USD |
OTCM |
Apr 19, 15:59
Northwest Biotherapeutics Cash from Investing (Quarterly): -0.418M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.418M |
| September 30, 2023 | -0.437M |
| June 30, 2023 | -1.249M |
| March 31, 2023 | -1.333M |
| December 31, 2022 | -2.16M |
| September 30, 2022 | -0.276M |
| June 30, 2022 | -0.408M |
| March 31, 2022 | -0.058M |
| December 31, 2021 | -1.553M |
| September 30, 2021 | -2.691M |
| June 30, 2021 | -1.507M |
| March 31, 2021 | -0.264M |
| December 31, 2020 | -3.034M |
| September 30, 2020 | -3.802M |
| June 30, 2020 | -1.244M |
| March 31, 2020 | -0.062M |
| December 31, 2019 | -0.114M |
| September 30, 2019 | -0.021M |
| June 30, 2019 | -0.061M |
| March 31, 2019 | -0.164M |
| December 31, 2018 | 45.40M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.006M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.005M |
| June 30, 2017 | -0.007M |
| March 31, 2017 | 0.218M |
| December 31, 2016 | -0.169M |
| September 30, 2016 | -0.467M |
| June 30, 2016 | -1.62M |
| March 31, 2016 | -2.683M |
| December 31, 2015 | -2.741M |
| September 30, 2015 | -1.995M |
| June 30, 2015 | -0.882M |
| March 31, 2015 | -1.133M |
| December 31, 2014 | -11.40M |
| September 30, 2014 | -21.54M |
| June 30, 2014 | -3.414M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 4.555M |
| September 30, 2013 | -4.554M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.004M |
| June 30, 2012 | -0.027M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.018M |
| September 30, 2011 | -0.028M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.802M
Minimum
Sep 2020
-0.021M
Maximum
Sep 2019
-1.089M
Average
-0.437M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.96M |
| Cash from Financing (Quarterly) | 14.42M |
| Free Cash Flow | -57.07M |
| Free Cash Flow Per Share (Quarterly) | -0.015 |
| Free Cash Flow to Equity (Quarterly) | -25.23M |
| Free Cash Flow Yield | -10.63% |